New exposure biomarkers as tools for breast cancer epidemiology, biomonitoring, and prevention: A systematic approach based on animal evidence

Environmental Health Perspectives

Volumn 122, Issue 9, 2014, Pages 881-895

  Rudel, Ruthann A ^a   Ackerman, Janet M ^a   Attfield, Kathleen R ^a,b   Brody, Julia Green ^a  

^a Silent Spring Institute   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CARCINOGEN;

ANIMAL; BREAST NEOPLASMS; COHORT ANALYSIS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; EXPERIMENTAL MAMMARY NEOPLASM; FEMALE; HUMAN; OCCUPATIONAL EXPOSURE; PROCEDURES; RISK ASSESSMENT; RODENT;

ANIMALS; BIOMARKERS; BREAST NEOPLASMS; CARCINOGENS; COHORT STUDIES; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; FEMALE; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; OCCUPATIONAL EXPOSURE; RISK ASSESSMENT; RODENTIA;

EID: 84906875113     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1307455     Document Type: Review

References (168)

1. Alwis KU, Blount BC, Britt AS, Patel D, Ashley DL. 2012. Simultaneous analysis of 28 urinary VOC metabolites using ultra high performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry (UPLC-ESI/MSMS). Anal Chim Acta 750:152-160.
2. Ambrosone CB, Abrams SM, Gorlewska-Roberts K, Kadlubar FF. 2007. Hair dye use, meat intake, and tobacco exposure and presence of carcinogen-DNA adducts in exfoliated breast ductal epithelial cells. Arch Biochem Biophys 464:169-175.
3. American Cancer Society. 2010. The Global Economic Cost of Cancer. Available: http://www.cancer.org/acs/groups/content/@internationalaffairs/documents/document/acspc-026203.pdf [accessed 7 April 2014].
4. Arlt VM, Schwerdtle T. 2011. UKEMS/Dutch EMS-sponsored workshop on biomarkers of exposure and oxidative DNA damage & 7th GUM-32P-postlabelling workshop, University of Munster, Munster, Germany, 28-29 March 2011. Mutagenesis 26:679-685.
5. Barnes BB, Steindorf K, Hein R, Flesch-Janys D, Chang- Claude J. 2011. Population attributable risk of invasive postmenopausal breast cancer and breast cancer subtypes for modifiable and non-modifiable risk factors. Cancer Epidemiol 35:345-352.
6. Barr DB, Barr JR, Bailey SL, Lapeza CR, Beeson MD, Caudill SP, et al. 2000. Levels of methyleugenol in a subset of adults in the general U.S. population as determined by high resolution mass spectrometry. Environ Health Perspect 108:323-328.
7. Bellinger DC. 2012. A strategy for comparing the contributions of environmental chemicals and other risk factors to neurodevelopment of children. Environ Health Perspect 120:501-507; doi:10.1289/ehp.1104170.
8. Bessette EE, Spivack SD, Goodenough AK, Wang T, Pinto S, Kadlubar FF, et al. 2010. Identification of carcinogen DNA adducts in human saliva by linear quadrupole ion trap/multistage tandem mass spectrometry. Chem Res Toxicol 23:1234-1244.
9. Bessette EE, Yasa I, Dunbar D, Wilkens LR, Le Marchand L, Turesky RJ. 2009. Biomonitoring of carcinogenic heterocyclic aromatic amines in hair: a validation study. Chem Res Toxicol 22:1454-1463.
10. Bevan R, Angerer J, Cocker J, Jones K, Koch HM, Sepai O, et al. 2012. Framework for the development and application of environmental biological monitoring guidance values. Regul Toxicol Pharmacol 63:453-460.
11. Birnbaum LS, Fenton SE. 2003. Cancer and developmental exposure to endocrine disruptors. Environ Health Perspect 111:389-394.
12. Blair IA. 2010. Analysis of estrogens in serum and plasma from postmenopausal women: past present, and future. Steroids 75:297-306.
13. Blount BC, Kobelski RJ, McElprang DO, Ashley DL, Morrow JC, Chambers DM, et al. 2006. Quantification of 31 volatile organic compounds in whole blood using solid-phase microextraction and gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 832:292-301.
14. Blount BC, McElprang DO, Chambers DM, Waterhouse MG, Squibb KS, Lakind JS. 2010. Methodology for collecting, storing, and analyzing human milk for volatile organic compounds. J Environ Monit 12:1265-1273.
15. Blum A, Gold MD, Ames BN, Jones FR, Hett EA, Dougherty RC, et al. 1978. Children absorb tris-BP flame retardant from sleepwear: urine contains the mutagenic metabolite, 2,3-dibromopropanol. Science 201:1020-1023.
16. Boogaard PJ. 2002. Use of haemoglobin adducts in exposure monitoring and risk assessment. J Chromatogr B Analyt Technol Biomed Life Sci 778:309-322.
17. Boudreau A, van't Veer LJ, Bissell MJ. 2012. An "elite hacker": breast tumors exploit the normal microenvironment program to instruct their progression and biological diversity. Cell Adh Migr 6:236-248.
18. Boysen G, Hecht SS. 2003. Analysis of DNA and protein adducts of benzo[a]pyrene in human tissues using structure-specific methods. Mutat Res 543:17-30.
19. Brody J. 2010. Everyday exposures and breast cancer. Rev Environ Health 25:1-7.
20. Brody JG, Moysich KB, Humblet O, Attfield KR, Beehler GP, Rudel RA. 2007a. Environmental pollutants and breast cancer: epidemiologic studies. Cancer 109:2667-2711.
21. Brody JG, Rudel RA. 2008. Environmental pollutants and breast cancer: the evidence from animal and human studies. Breast Dis Year Book Q 19:17-19.
22. Brody JG, Rudel RA, Michels KB, Moysich KB, Bernstein L, Attfield KR, et al. 2007b. Environmental pollutants, diet, physical activity, body size, and breast cancer: where do we stand in research to identify opportunities for prevention? Cancer 109:2627-2634.
23. Brown NM, Manzolillo PA, Zhang JX, Wang J, Lamartiniere CA. 1998. Prenatal TCDD and predisposition to mammary cancer in the rat. Carcinogenesis 19:1623-1629.
24. Budavari S, O'Neil M, Smith A, P. Heckelman, Obenchain J. 1996. The Merck Index. 12th ed. An Encyclopedia of Chemicals, Drugs and Biologicals. Whitehouse Station, NJ:Merck & Co.
25. Calafat AM, Barr DB, Pirkle JL, Ashley DL. 1999. Reference range concentrations of N-acetyl-S-(2-hydroxyethyl)-l-cysteine, a common metabolite of several volatile organic compounds, in the urine of adults in the United States. J Expo Anal Environ Epidemiol 9:336-342.
26. Calafat AM, Koch HM, Swan SH, Hauser R, Goldman LR, Lanphear BP, et al. 2013. Misuse of blood serum to assess exposure to bisphenol A and phthalates [Letter]. Breast Cancer Res 15:403.
27. California OEHHA (California Office of Environmental Health Hazard Assessment). 2014. Proposition 65-Current Proposition 65 List [06/06/14]. Available: http://www.oehha.ca.gov/prop65/prop65_list/Newlist.html [accessed 7 April 2014].
28. Camann DE, Schultz ST, Yau AY, Heilbrun LP, Zuniga MM, Palmer RF, et al. 2012. Acetaminophen, pesticide, and diethylhexyl phthalate metabolites, anandamide, and fatty acids in deciduous molars: potential biomarkers of perinatal exposure. J Expo Sci Environ Epidemiol 23:190-196.
29. Cao Z, Swift TA, West CA, Rosano TG, Rej R. 2004. Immunoassay of estradiol: unanticipated suppression by unconjugated estriol. Clin Chem 50:160-165.
30. Cardiff RD, Bern HA, Faulkin LJ, Daniel CW, Smith GH, Young LJ, et al. 2002. Contributions of mouse biology to breast cancer research. Comp Med 52:12-31.
31. Carmella SG, Chen M, Han S, Briggs A, Jensen J, Hatsukami DK, et al. 2009. Effects of smoking cessation on eight urinary tobacco carcinogen and toxicant biomarkers. Chem Res Toxicol 22:734-741.
32. CDC (Centers For Disease Control and Prevention). 2008. 2003-2004 Data Documentation, Code Book, And Frequencies: Acrylamide And Glycidamide (L06Age_C). Available: http://wwwn.cdc.gov/nchs/nhanes/2003-2004/L06AGE_C.htm [accessed 3 July 2014].
33. CDC (Centers For Disease Control and Prevention). 2009. Fourth National Report on Human Exposure to Environmental Chemicals. Available: http://www.cdc.gov/exposurereport/pdf/FourthReport.pdf [accessed 27 June 2014].
34. CDC (Centers For Disease Control and Prevention). 2012. Fourth National Report on Human Exposure to Environmental Chemicals: Updated Tables, February 2012. Available: http://www.cdc.gov/exposurereport/pdf/FourthReport_UpdatedTables_Feb2012.pdf [accessed 3 July 2014].
35. CDC (Centers For Disease Control and Prevention). 2014. National Health and Nutrition Examination Survey. Available: http://www.cdc.gov/nchs/nhanes.htm [accessed 7 April 2014].
36. Cogliano VJ, Baan R, Straif K, Grosse Y, Lauby-Secretan B, El Ghissassi F, et al. 2011. Preventable exposures associated with human cancers. J Natl Cancer Inst 103:1827-1839.
37. Cohn BA, Wolff MS, Cirillo PM, Sholtz RI. 2007. DDT and breast cancer in young women: new data on the significance of age at exposure. Environ Health Perspect 115:1406-1414; doi:10.1289/ehp.10260.
38. Collishaw NE, Boyd NF, Cantor KP, Hammond SK, Johnson KC, Millar J, et al. 2009. Canadian Expert Panel on Tobacco Smoke and Breast Cancer Risk. Toronto, Ontario, Canada:Ontario Tobacco Research Unit.
39. Conway K, Edmiston SN, Cui L, Drouin SS, Pang J, He M, et al. 2002. Prevalence and spectrum of p53 mutations associated with smoking in breast cancer. Cancer Res 62:1987-1995.
40. Cooper EM, Covaci A, van Nuijs AL, Webster TF, Stapleton HM. 2011. Analysis of the flame retardant metabolites bis(1,3- dichloro-2-propyl) phosphate (BDCPP) and diphenyl phosphate (DPP) in urine using liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem 401:2123-2132.
41. Cope KA, Watson MT, Foster WM, Sehnert SS, Risby TH. 2004. Effects of ventilation on the collection of exhaled breath in humans. J Appl Physiol 96:1371-1379.
42. Coronado GD, Holte S, Vigoren E, Griffith WC, Barr DB, Faustman E, et al. 2011. Organophosphate pesticide exposure and residential proximity to nearby fields: evidence for the drift pathway. J Occup Environ Med 53:884-891.
43. Covaci A, de Boer J, Ryan JJ, Voorspoels S, Schepens P. 2002. Distribution of organobrominated and organochlorinated contaminants in Belgian human adipose tissue. Environ Res 88:210-218.
44. Czene K, Osterman-Golkar S, Yun X, Li G, Zhao F, Pérez HL, et al. 2002. Analysis of DNA and hemoglobin adducts and sister chromatid exchanges in a human population occupationally exposed to propylene oxide: a pilot study. Cancer Epidemiol Biomarkers Prev 11:315-318.
45. De Alwis GKH, Needham LL, Barr DB. 2007. Automated solid phase extraction and quantitative measurement of 2,3-dibromo-1-propanol in urine using gas chromatography-mass spectrometry. Arch Environ Contam Toxicol 53:134-139.
46. Delclos KB, Blaydes B, Heflich RH, Smith BA. 1996. Assessment of DNA adducts and the frequency of 6-thioguanine resistant T-lymphocytes in F344 rats fed 2,4-toluenediamine or implanted with a toluenediisocyanate-containing polyester polyurethane foam. Mutat Res 367:210-218.
47. Dewailly É, Mulvad G, Pedersen HS, Ayotte P, Demers A, Weber JP, et al. 1999. Concentration of organochlorines in human brain, liver, and adipose tissue autopsy samples from Greenland. Environ Health Perspect 107:823-828.
48. DHHS (Department of Health and Human Services). 2004. Household Products Database: Health and Safety Information on Household Products Chemical Information. Available: http://householdproducts.nlm.nih.gov/[accessed 20 June 2005].
49. D'Hollander W, de Voogt P, De Coen W, Bervoets L. 2010. Perfluorinated substances in human food and other sources of human exposure. Rev Environ Contam Toxicol 208:179-215.
50. Dodson RE, Houseman EA, Levy JI, Spengler JD, Shine JP, Bennett DH. 2007. Measured and modeled personal exposures to and risks from volatile organic compounds. Environ Sci Technol 41:8498-8505.
51. Dodson RE, Nishioka M, Standley LJ, Perovich LJ, Brody JG, Rudel RA. 2012. Endocrine disruptors and asthma-associated chemicals in consumer products. Environ Health Perspect 120:935-943; doi:10.1289/ehp.1104052.
52. ECHA (European Chemicals Agency). 2013. Candidate List of Substances of Very High Concern for Authorisation. Available: http://echa.europa.eu/candidate-list-table [accessed 7 April 2014].
53. Environmental Defense Fund. 2004. Scorecard: The Pollution Information Site. Available:https://web.archive.org/web/20050730082500//http://www.scorecard.org/[accessed 30 June 2005].
54. Environmental Health Risk in European Birth Cohorts (ENRIECO). 2010. Inventory of ENRIECO Cohorts. Available: http://birthcohortsenrieco.net [accessed 7 April 2014].
55. Esteban M, Castaño A. 2009. Non-invasive matrices in human biomonitoring: a review. Environ Int 35:438-449.
56. Falk RT, Gentzschein E, Stanczyk FZ, Garcia-Closas M, Figueroa JD, Ioffe OB, et al. 2012. Sex steroid hormone levels in breast adipose tissue and serum in postmenopausal women. Breast Cancer Res Treat 131:287-294.
57. Fernandez MF, Santa-Marina L, Ibarluzea JM, Exposito J, Aurrekoetxea JJ, Torne P, et al. 2007. Analysis of population characteristics related to the total effective xenoestrogen burden: a biomarker of xenoestrogen exposure in breast cancer. Eur J Cancer 43:1290-1299.
58. Food and Drug Administration. 2005. "Everything" Added to Food in the United States (EAFUS): A Food Additive Database. Available: http://vm.cfsan.fda.gov/?dms/eafus.html [accessed 30 June 2005].
59. Friedman GD, Jiang SF, Udaltsova N, Chan J, Quesenberry CP Jr, Habel LA. 2009. Pharmaceuticals that cause mammary gland tumors in animals: findings in women. Breast Cancer Res Treat 116:187-194.
60. Gold LS, Slone TH, Manley NB, Bernstein L. 1991. Target organs in chronic bioassays of 533 chemical carcinogens. Environ Health Perspect 93:233-246.
61. Gold L, Slone TH, Manley NB, Garfinkel GB, Ames BN. 2005. Summary of Carcinogenic Potency Database by Target Organ. Available: http://toxnet.nlm.nih.gov/cpdb/pdfs/CPDBPathology.pdf [accessed 7 April 2014].
62. Haseman J, Huff J. 1987. Species correlation in long-term carcinogenicity studies. Cancer Lett 37:125-132.
63. Health Canada. 2001. Canadian Environmental Protection Act, 1999: Priority Substances List Assessment Report: Ethylene Oxide. 0-662-28980-3. Available: http://publications.gc.ca/collections/Collection/En40-215-51E.pdf [accessed 1 July 2014].
64. Henderson TO, Amsterdam A, Bhatia S, Hudson MM, Meadows AT, Neglia JP, et al. 2010. Systematic review: surveillance for breast cancer in women treated with chest radiation for childhood, adolescent, or young adult cancer. Ann Intern Med 152:444-455.
65. Hester TR, Ford NF, Gale PJ, Hammett JL, Raymond R, Turnbull D, et al. 1997. Measurement of 2,4-toluenediamine in urine and serum samples from women with Même or Replicon breast implants. Plast Reconstr Surg 100:1291-1298.
66. Hoehle SI, Knudsen GA, Sanders JM, Sipes IG. 2009. Absorption, distribution, metabolism, and excretion of 2,2-bis(bromomethyl)-1,3-propanediol in male Fischer-344 rats. Drug Metab Dispos 37:408-416.
67. Hooper DG, Bolton VE, Guilford FT, Straus DC. 2009. Mycotoxin detection in human samples from patients exposed to environmental molds. Int J Mol Sci 10:1465-1475.
68. Hoover RN, Hyer M, Pfeiffer RM, Adam E, Bond B, Cheville AL, et al. 2011. Adverse health outcomes in women exposed in utero to diethylstilbestrol. N Engl J Med 365:1304-1314.
69. Huff J. 1993. Chemicals and cancer in humans: first evidence in experimental animals. Environ Health Perspect 100:201-210.
70. Huff J. 1996. Chemically induced cancers in hormonal organs of laboratory animals and of humans. In: Cellular and Molecular Mechanisms of Hormonal Carcinogenesis: Environmental Influences (Huff J, Boyd J, Barrett JC, eds). New York:Wiley-Liss Inc., 77-102.
71. Huff J. 1999. Animal and human carcinogens [Letter]. Environ Health Perspect 107:A341-A342.
72. Huff J, Jacobson MF, Davis DL. 2008. The limits of two-year bioassay exposure regimens for identifying chemical carcinogens. Environ Health Perspect 116:1439-1442; doi:10.1289/ehp.10716.
73. Huff J, Melnick R. 2006. What are the real causes of cancer? Int J Occup Environ Health 12:81-86.
74. Huyck S, Ohman-Strickland P, Zhang L, Tong J, Xu XU, Zhang JJ. 2010. Determining times to maximum urine excretion of 1-aminopyrene after diesel exhaust exposure. J Expo Sci Environ Epidemiol 20:650-655.
75. IARC (International Agency for Research on Cancer). 1993. Ochratoxin A. IARC Monogr Eval Carcinog Risks Hum 56:489-521. Available: http://monographs.iarc.fr/ENG/Monographs/vol56/mono56-18.pdf [accessed 30 June 2014].
76. IARC (International Agency for Research on Cancer). 2002. Some Traditional Herbal Medicines, Some Mycotoxins, Naphthalene and Styrene. IARC Monogr Eval Carcinog Risks Hum 82. Available: http://monographs.iarc.fr/ENG/Monographs/vol82/mono82.pdf [accessed 30 June 2014].
77. IARC (International Agency for Research on Cancer). 2006. Preamble to the IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Available: http://monographs.iarc.fr/ENG/Preamble/CurrentPreamble.pdf [accessed 10 July 2014].
78. IARC (International Agency for Research on Cancer). 2010. Identification of Research Needs to Resolve the Carcinogenicity of High-Priority IARC Carcinogens. Technical Publication No. 42. Available: http://monographs.iarc.fr/ENG/Publications/techrep42/TR42-Full.pdf [accessed 19 June 2014].
79. IARC (International Agency for Research on Cancer). 2012. A Review of Human Carcinogens. IARC Monogr Eval Carcinog Risks Hum 100. Available: http://monographs.iarc.fr/ENG/Monographs/PDFs/index.php [accessed 30 June 2014].
80. IBCERCC (Interagency Breast Cancer & Environmental Research Coordinating Committee). 2013. Breast Cancer and the Environment: Prioritizing Prevention. Available: http://www.niehs.nih.gov/about/boards/ibcercc/[accessed 19 June 2014].
81. Il'yasova D, McCarthy BJ, Erdal S, Shimek J, Goldstein J, Doerge DR, et al. 2009. Human exposure to selected animal neurocarcinogens: a biomarker-based assessment and implications for brain tumor epidemiology. J Toxicol Environ Health B Crit Rev 12:175-187.
82. IOM (Institute of Medicine). 2011. Breast Cancer and the Environment: A Life Course Approach. Washington DC:National Academies Press. Available: http://www.iom.edu/Reports/2011/Breast-Cancer-and-the-Environment-A-Life-Course-Approach.aspx [accessed 19 June 2014].
83. Izzotti A, Camoirano A, Cartiglia C, Grubbs CJ, Lubet RA, Kelloff GJ, et al. 1999. Patterns of DNA adduct formation in liver and mammary epithelial cells of rats treated with 7,12-dimethylbenz(a)anthracene, and selective effects of chemopreventive agents. Cancer Res 59:4285-4290.
84. Jones CR, Liu YY, Sepai O, Yan H, Sabbioni G. 2005. Hemoglobin adducts in workers exposed to nitrotoluenes. Carcinogenesis 26:133-143.
85. Käfferlein HU, Marczynski B, Mensing T, Brüning T. 2010. Albumin and hemoglobin adducts of benzo[a]pyrene in humans- analytical methods, exposure assessment, and recommendations for future directions. Crit Rev Toxicol 40:126-150.
86. Koch HM, Preuss R, Angerer J. 2006. Di(2-ethylhexyl)phthalate (DEHP): human metabolism and internal exposure-an update and latest results. Int J Androl 29:155-165.
87. Kong W, Kuester RK, Gallegos A, Sipes IG. 2011. Induction of DNA damage in human urothelial cells by the brominated flame retardant 2,2-bis(bromomethyl)-1,3-propanediol: role of oxidative stress. Toxicology 290:271-277.
88. Land CE. 1995. Studies of cancer and radiation dose among atomic bomb survivors. The example of breast cancer. JAMA 274:402-407.
89. Lash TL, Aschengrau A. 1999. Active and passive cigarette smoking and the occurrence of breast cancer. Am J Epidemiol 149:5-12.
90. Lau C, Anitole K, Hodes C, Lai D, Pfahles-Hutchens A, Seed J. 2007. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol Sci 99:366-394.
91. Laumbach R, Tong J, Zhang L, Ohman-Strickland P, Stern A, Fiedler N, et al. 2009. Quantification of 1-aminopyrene in human urine after a controlled exposure to diesel exhaust. J Environ Monit 11:153-159.
92. Legay C, Rodriguez MJ, Miranda-Moreno L, Serodes JB, Levallois P. 2011. Multi-level modelling of chlorination by-product presence in drinking water distribution systems for human exposure assessment purposes. Environ Monit Assess 178:507-524.
93. Li Z, Sandau CD, Romanoff LC, Caudill SP, Sjodin A, Needham LL, et al. 2008. Concentration and profile of 22 urinary polycyclic aromatic hydrocarbon metabolites in the US population. Environ Res 107:320-331.
94. Luo J, Horn K, Ockene JK, Simon MS, Stefanick ML, Tong E, et al. 2011. Interaction between smoking and obesity and the risk of developing breast cancer among postmenopausal women: the Women's Health Initiative Observational Study. Am J Epidemiol 174:919-928.
95. MacMahon B, Trichopoulos D, Cole P, Brown J. 1982. Cigarette smoking and urinary estrogens. N Engl J Med 307:1062-1065.
96. Manjanatha MG, Lyn-Cook LE, Culp SJ, Beland FA, Heflich RH, Aidoo A. 1996. Lymphocyte mutant frequency in relation to DNA adduct formation in rats treated with tumorigenic doses of the mammary gland carcinogen 7,12-dimethylbenz[a]anthracene. Mutat Res 357:89-96.
97. McDonald TA, Komulainen H. 2005. Carcinogenicity of the chlorination disinfection by-product MX. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 23:163-214.
98. Michels KB, Mohllajee AP, Roset-Bahmanyar E, Beehler GP, Moysich KB. 2007. Diet and breast cancer: a review of the prospective observational studies. Cancer 109:2712-2749.
99. Mills D, Gordon EJ, Casano A, Lahti SM, Nguyen T, Preston A, et al. 2011. The physiology of the normal human breast: an exploratory study. J Physiol Biochem 67:621-627.
100. Muñoz K, Blaszkewicz M, Degen GH. 2009. Simultaneous analsis of ochratoxin A and its major metabolite ochratoxin alpha in plasma and urine for an advanced biomonitoring of the mycotoxin. J Chromatogr B Analyt Technol Biomed Life Sci 878:2623-2629.
101. National Cancer Institute. 2013. EGRP-Supported Cancer Epidemiology Consortia. Available: http://epi.grants.cancer.gov/Consortia [accessed 7 April 2014].
102. National Cancer Institute. 2014. Cancer Control and Population Sciences: Biospecimen Resources for Population Scientists. Available: http://epi.grants.cancer.gov/biospecimens.html [accessed 7 April 2014].
103. National Institute for Occupational Safety and Health. 1990. National Occupational Exposure Survey (NOES) (1981-1983). Available: http://www.cdc.gov/noes/default.html [accessed 30 June 2005].
104. NIH (National Institutes of Health). 2009. NIH Computer Retrieval of Information on Scientific Projects. Available: http://crisp.cit.nih.gov/crisp [accessed 1 December 2009].
105. NIH (National Institutes of Health). 2012. NIH RePORTER. Available: http://projectreporter.nih.gov/reporter.cfm [accessed 10 December 2012].
106. NTP (National Toxicology Program). 1978. Technical Report 131: Bioassays of DDT, TDE, and p,p'-DDE for Possible Caracinogenicity. CAS No. 50-29-3, 72-54-8, 72-55-9. NCI-CG-TR-131. TR-131. Available: http://ntp.niehs.nih.gov/ntp/htdocs/LT_rpts/tr131.pdf [accessed April 4 2014].
107. NTP (National Toxicology Program). 2002. Tetrabromobisphenol A bis(2,3-Dibromopropyl Ether) [21850-44-2]: Review of Toxicological Literature. Research Triangle Park, NC:NTP. Available: http://ntp.niehs.nih.gov/ntp/htdocs/Chem_Background/ExSumPdf/TBBPA-BDPE_508.pdf [accessed 30 June 2014].
108. NTP (National Toxicology Program). 2005a. 11th Report on Carcinogens. Available: http://ntp.niehs.nih.gov/ntp/roc/toc11.htm [accessed 7 April 2014].
109. NTP (National Toxicology Program). 2005b. Study Reports and Abstracts Collection. Available: http://ntpsearch.niehs.nih.gov/texis/search/?pr=ntp_web_entire_site_all&mu=Study+Reports+and+Abstracts [accessed 7 April 2014].
110. NTP (National Toxicology Program). 2011. Report on Carcinogens: Twelfth Edition, 2011. Available: http://ntp.niehs.nih.gov/ntp/roc/twelfth/roc12.pdf [accessed 7 April 2014].
111. Nurses' Health Study. 2014. Guidelines for External Collaborators: Use of the Nurses' Health Studies Biospecimens. Available: http://www.channing.harvard.edu/nhs/?page_id=476 [accessed 2 April 2014].
112. Occupational Safety and Health Administration. 2012. 1,3-Butadiene. Available: http://www.osha.gov/SLTC/butadiene [accessed 7 April 2014].
113. Ogawa M, Oyama T, Isse T, Yamaguchi T, Murakami T, Endo Y, et al. 2006. Hemoglobin adducts as a marker of exposure to chemical substances, especially PRTR class I designated chemical substances. J Occup Health 48:314-328.
114. Oyesanmi O, Snyder D, Sullivan N, Reston J, Treadwell J, Schoelles KM. 2010. Alcohol Consumption and Cancer Risk: Understanding Possible Causal Mechanisms for Breast and Colorectal Cancers. Evidence Report/Technology Assessment No. 197. ECRI Institute Evidence-based Practice Center. AHRQ Publication No. 11-E003. Rockville, MD:Agency for Healthcare Resarch and Quality.
115. Palmer JR, Rosenberg L. 1993. Cigarette smoking and the risk of breast cancer. Epidemiol Rev 15:145-156.
116. Park YH, Lee K, Soltow QA, Strobel FH, Brigham KL, Parker RE, et al. 2012. High-performance metabolic profiling of plasma from seven mammalian species for simultaneous environmental chemical surveillance and bioeffect monitoring. Toxicology 295:47-55.
117. Patel CJ, Bhattacharya J, Butte AJ. 2010. An Environment-Wide Association Study (EWAS) on type 2 diabetes mellitus. PLoS One 5:e10746; doi:10.1371/journal.pone.0010746.
118. Patel C, Chen R, Kodama K, Ioannidis J, Butte A. 2013. Systematic identification of interaction effects between genome-and environment-wide associations in type 2 diabetes mellitus. Hum Genet 132(5):495-508.
119. Perera FP, Weinstein IB. 2000. Molecular epidemiology: recent advances and future directions. Carcinogenesis 21:517-524.
120. Pesticide Action Network. 2000. Pesticide Action Network Pesticides Database. Available: http://www.pesticideinfo.org [accessed 30 June 2005.
121. Petracci E, Decarli A, Schairer C, Pfeiffer RM, Pee D, Masala G, et al. 2011. Risk factor modification and projections of absolute breast cancer risk. J Natl Cancer Inst 103:1037-1048.
122. Plebani C, Tranfo G, Salerno A, Panebianco A, Marcelloni AM. 1999. An optimized sampling and GC-MS analysis method for benzene in exhaled breath, as a biomarker for occupational exposure. Talanta 50:409-412.
123. President's Cancer Panel. 2010. Reducing Environmental Cancer Risk, What We Can Do Now. Bethesda, MD:National Institutes of Health National Cancer Institute. Available: http://deainfo.nci.nih.gov/advisory/pcp/annualReports/pcp08-09rpt/PCP_Report_08-09_508.pdf [accessed 27 June 2014].
124. Quirós-Alcalá L, Bradman A, Nishioka M, Harnly ME, Hubbard A, McKone TE, et al. 2011. Pesticides in house dust from urban and farmworker households in California: an observational measurement study. Environ Health 10:19; doi:10.1186/1476-069X-10-19.
125. Rad G, Hoehle SI, Kuester RK, Sipes IG. 2010. In vitro glucuronidation of 2,2-bis(bromomethyl)-1,3-propanediol by microsomes and hepatocytes from rats and humans. Drug Metab Dispos 38:957-962.
126. Rall DP. 2000. Laboratory animal tests and human cancer. Drug Metab Rev 32:119-128.
127. Rappaport SM. 2011. Implications of the exposome for exposure science. J Expo Sci Environ Epidemiol 21:5-9.
128. Rappaport SM. 2012. Biomarkers intersect with the exposome. Biomarkers 17:483-489.
129. Rappaport SM, Li H, Grigoryan H, Funk WE, Williams ER. 2012. Adductomics: characterizing exposures to reactive electrophiles. Toxicol Lett 213:83-90.
130. Rasmussen TH, Nielsen F, Andersen HR, Nielsen JB, Weihe P, Grandjean P. 2003. Assessment of xenoestrogenic exposure by a biomarker approach: application of the E-Screen bioassay to determine estrogenic response of serum extracts. Environ Health 2:12; doi:10.1186/1476-069X-2-12.
131. Reynolds P. 2013. Smoking and breast cancer. J Mammary Gland Biol Neoplasia 18:15-23.
132. Richardson SD, Plewa MJ, Wagner ED, Schoeny R, Demarini DM. 2007. Occurrence, genotoxicity, and carcinogenicity of regulated and emerging disinfection by-products in drinking water: a review and roadmap for research. Mutat Res 636:178-242.
133. Riederer AM, Bartell SM, Barr DB, Ryan PB. 2008. Diet and nondiet predictors of urinary 3-phenoxybenzoic acid in NHANES 1999-2002. Environ Health Perspect 116:1015-1022; doi:10.1289/ehp.11082.
134. Rosner W, Hankinson SE, Sluss PM, Vesper HW, Wierman ME. 2013. Challenges to the measurement of estradiol: an endocrine society position statement. J Clin Endocrinol Metab 98:1376-1387.
135. Rothman N, Stewart WF, Schulte PA. 1995. Incorporating biomarkers into cancer epidemiology: a matrix of biomarker and study design categories. Cancer Epidemiol Biomarkers Prev 4:301-311.
136. Rudel RA, Attfield KR, Schifano JN, Brody JG. 2007. Chemicals causing mammary gland tumors in animals signal new directions for epidemiology, chemicals testing, and risk assessment for breast cancer prevention. Cancer 109:2635-2666.
137. Rudel RA, Camann DE, Spengler JD, Korn LR, Brody JG. 2003. Phthalates, alkylphenols, pesticides, polybrominated diphenyl ethers, and other endocrine-disrupting compounds in indoor air and dust. Environ Sci Technol 37:4543-4553.
138. Rudel RA, Fenton SE, Ackerman JM, Euling SY, Makris SL. 2011. Environmental exposures and mammary gland development: state of the science, public health implications, and research recommendations. Environ Health Perspect 119:1053-1061; doi:10.1289/ehp.1002864.
139. Rudel R, Perovich L. 2012. Accurate risk-based chemical screening relies on robust exposure estimates [Letter]. Toxicol Sci 128:295-296.
140. Ruden DM, Xiao L, Garfinkel MD, Lu X. 2005. Hsp90 and environmental impacts on epigenetic states: a model for the trans-generational effects of diethylstilbesterol on uterine development and cancer. Hum Mol Genet 14:R149-R155.
141. Russo IH, Russo J. 1996. Mammary gland neoplasia in long-term rodent studies. Environ Health Perspect 104:938-967.
142. Russo J, Russo IH. 1993. Development pattern of human breast and susceptibility to carcinogenesis. Eur J Cancer Prev 2(suppl 3):85-100.
143. Russo J, Russo IH. 2004. Molecular Basis of Breast Cancer. New York:Springer.
144. Sanchez MN, Garcia EH, Pavon JL, Cordero BM. 2012. Fast analytical methodology based on mass spectrometry for the determination of volatile biomarkers in saliva. Anal Chem 84:379-385.
145. Savitz DA. 2012. Invited commentary: biomarkers of exposure to drinking water disinfection by-products-are we ready yet? Am J Epidemiol 175:276-278.
146. Schettgen T, Müller J, Fromme H, Angerer J. 2010. Simultaneous quantification of haemoglobin adducts of ethylene oxide, propylene oxide, acrylonitrile, acrylamide and glycidamide in human blood by isotope-dilution GC/NCI-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 878:2467-2473.
147. Scott PM. 2005. Biomarkers of human exposure to ochratoxin A. Food Addit Contam 22(suppl 1):99-107.
148. Shantakumar S, Gammon MD, Eng SM, Sagiv SK, Gaudet MM, Teitelbaum SL, et al. 2005. Residential environmental exposures and other characteristics associated with detectable PAH-DNA adducts in peripheral mononuclear cells in a population-based sample of adult females. J Expo Anal Environ Epidemiol 15:482-490.
149. Snedeker SM. 2001. Pesticides and breast cancer risk: a review of DDT, DDE, and dieldrin. Environ Health Perspect 109(suppl 1):35-47.
150. Sonnenschein C, Soto AM. 2013. The aging of the 2000 and 2011 Hallmarks of Cancer reviews: a critique. J Biosci 38:651-663.
151. Stanczyk FZ, Clarke NJ. 2010. Advantages and challenges of mass spectrometry assays for steroid hormones. J Steroid Biochem Mol Biol 121:491-495.
152. Stevens RG. 2009. Light-at-night, circadian disruption and breast cancer: assessment of existing evidence. Int J Epidemiol 38:963-970.
153. Swenberg JA, Bordeerat NK, Boysen G, Carro S, Georgieva NI, Nakamura J, et al. 2011. 1,3-Butadiene: biomarkers and application to risk assessment. Chem Biol Interact 192:150-154.
154. Teeguarden JG, Calafat AM, Ye X, Doerge DR, Churchwell MI, Gunawan R, et al. 2011. Twenty-four hour human urine and serum profiles of bisphenol a during high-dietary exposure. Toxicol Sci 123:48-57.
155. Toriba A, Kitaoka H, Dills RL, Mizukami S, Tanabe K, Takeuchi N, et al. 2007. Identification and quantification of 1-nitropyrene metabolites in human urine as a proposed biomarker for exposure to diesel exhaust. Chem Res Toxicol 20:999-1007.
156. U.S. EPA (U.S. Environmental Protection Agency). 2005a. Exposure Assessment Tools and Models: Source Ranking Database. Available: http://www.epa.gov/opptintr/exposure/pubs/srd.htm [accessed 7 April 2014].
157. U.S. EPA (U.S. Environmental Protection Agency). 2005b. Inventory Update Rule: Non-confidential Production Volume Information Submitted by Companies for Chemicals Under the 1986-2002 Inventory Update Rule (IUR). Available: http://www.epa.gov/hpv/pubs/general/hpvcolst.htm [accessed 30 June 2005.]
158. U.S. EPA (U.S. Environmental Protection Agency). 2010. Dyes Derived from Benzidine and its Congeners. Available: http://www.epa.gov/oppt/existingchemicals/pubs/actionplans/DCBActionPlan_06232010.noheader.pdf [accessed 7 April 2014].
159. U.S. EPA (U.S. Environmental Protection Agency). 2011a. Exposure Factors Handbook: 2011 Edition. Washington, DC:US. EPA. Available: http://www.epa.gov/ncea/efh/pdfs/efh-complete.pdf [accessed: 30 June 2014].
160. U.S. EPA (U.S. Environmental Protection Agency). 2011b. Toluene Diisocyanate (TDI) and Related Compounds Action Plan [RIN 2070-ZA14]. Available: http://www.epa.gov/oppt/existingchemicals/pubs/actionplans/tdi.pdf [accessed 7 April 2014].
161. U.S. EPA (U.S. Environmental Protection Agency). 2012. EPA Existing Chemicals Action Plans. Available: http://www.epa.gov/opptintr/existingchemicals/pubs/ecactionpln.html [accessed 7 April 2014].
162. Warner M, Mocarelli P, Samuels S, Needham L, Brambilla P, Eskenazi B. 2011. Dioxin exposure and cancer risk in the Seveso Women's Health Study. Environ Health Perspect 119:1700-1705; doi:10.1289/ehp.1103720.
163. Weisel CP, Kim H, Haltmeier P, Klotz JB. 1999. Exposure estimates to disinfection by-products of chlorinated drinking water. Environ Health Perspect 107:103-110.
164. White SS, Stanko JP, Kato K, Calafat AM, Hines EP, Fenton SE. 2011. Gestational and chronic low-dose PFOA exposures and mammary gland growth and differentiation in three generations of CD-1 mice. Environ Health Perspect 119:1070-1076; doi:10.1289/ehp.1002741.
165. Woloshin S, Schwartz LM, Welch HG. 2008. The risk of death by age, sex, and smoking status in the United States: putting health risks in context. J Natl Cancer Inst 100:845-853.
166. Xue F, Willett WC, Rosner BA, Hankinson SE, Michels KB. 2011. Cigarette smoking and the incidence of breast cancer. Arch Intern Med 171:125-133.
167. Yang XR, Chang-Claude J, Goode EL, Couch FJ, Nevanlinna H, Milne RL, et al. 2011. Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst 103:250-263.
168. Zwirner-Baier I, Neumann HG. 1999. Polycyclic nitroarenes (nitro-PAHs) as biomarkers of exposure to diesel exhaust. Mutat Res 441:135-144.